• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定型心绞痛患者的循环 hepassocin 水平与脂肪肝和肾功能有关。

Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function.

机构信息

Department of Emergency, E-Da Hospital, Kaohsiung 82445 Taiwan.

School of Medicine, College of Medicine, I-Shou University, Kaohsiung, 82445 Taiwan.

出版信息

Int J Med Sci. 2021 Jan 1;18(1):1-7. doi: 10.7150/ijms.50646. eCollection 2021.

DOI:10.7150/ijms.50646
PMID:33390768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7738965/
Abstract

Chronic kidney disease (CKD) is a major risk factor for coronary artery disease and it is often associated with hepatic steatosis. Hepassocin (also known as hepatocyte-derived fibrinogen related protein or fibrinogen-like 1) is a novel hepatokine that causes hepatic steatosis and induces insulin resistance. However, the role of hepassocin in renal function status remains unclear. Our objective was to investigate the association of plasma hepassocin level with fatty liver and renal function status in patients with stable angina. Plasma hepassocin levels were determined by enzyme-linked immunosorbent assays in 395 consecutive patients with stable angina. Renal function was defined as an estimated glomerular filtration rate (eGFR). Fatty liver was defined by ultrasonography and fibrosis-4 (FIB-4) index. With increasing hepassocin tertiles, patients had higher prevalence of fatty live, an increased waist-to-hip ratio, and neutrophil count, monocyte count, and FIB-4 index, higher levels of uric acid, blood urine nitrogen and higher sensitivity C-reactive protein. They also had incrementally lower eGFR, serum hemoglobin and albumin levels. In multiple linear stepwise regression analysis, only eGFR was significantly independent negatively associated with plasma hepassocin levels. Our results indicate that circulating hepassocin in patients with stable angina is associated with fatty liver and renal function, which suggests that increased plasma hepassocin may be involved in the pathogenesis of fatty liver and CKD.

摘要

慢性肾脏病 (CKD) 是冠状动脉疾病的主要危险因素,常伴有肝脂肪变性。Hepassocin(也称为肝细胞衍生的纤维蛋白原相关蛋白或纤维蛋白原样蛋白 1)是一种新的肝分泌物,可引起肝脂肪变性并诱导胰岛素抵抗。然而,Hepassocin 在肾功能状态中的作用尚不清楚。我们的目的是研究稳定型心绞痛患者血浆 Hepassocin 水平与脂肪肝和肾功能状态的关系。 通过酶联免疫吸附试验在 395 例连续稳定型心绞痛患者中测定血浆 Hepassocin 水平。肾功能定义为估算肾小球滤过率 (eGFR)。脂肪肝通过超声和纤维化 4 (FIB-4) 指数定义。 随着 Hepassocin 三分位的增加,患者脂肪肝的患病率更高,腰围与臀围比、中性粒细胞计数、单核细胞计数和 FIB-4 指数增加,尿酸、血尿素氮水平升高,高敏 C 反应蛋白水平升高。他们的 eGFR、血清血红蛋白和白蛋白水平也逐渐降低。在多元线性逐步回归分析中,只有 eGFR 与血浆 Hepassocin 水平呈显著负相关。 我们的研究结果表明,稳定型心绞痛患者循环中的 Hepassocin 与脂肪肝和肾功能有关,这表明血浆 Hepassocin 水平升高可能与脂肪肝和 CKD 的发病机制有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dace/7738965/8bb81bdfce5a/ijmsv18p0001g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dace/7738965/8bb81bdfce5a/ijmsv18p0001g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dace/7738965/8bb81bdfce5a/ijmsv18p0001g001.jpg

相似文献

1
Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function.稳定型心绞痛患者的循环 hepassocin 水平与脂肪肝和肾功能有关。
Int J Med Sci. 2021 Jan 1;18(1):1-7. doi: 10.7150/ijms.50646. eCollection 2021.
2
High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease.高 FIB-4 指数是非酒精性脂肪性肝病患者慢性肾脏病发病的独立危险因素。
Hepatol Int. 2016 Mar;10(2):340-6. doi: 10.1007/s12072-015-9690-5. Epub 2015 Dec 16.
3
Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease.血浆脂肪酸结合蛋白 4(FABP4)水平与稳定型心绞痛和慢性肾脏病患者异常 QTc 间期相关。
BMC Cardiovasc Disord. 2019 Jun 24;19(1):153. doi: 10.1186/s12872-019-1134-z.
4
Discovery of a role of the novel hepatokine, hepassocin, in obesity.发现新型肝分泌物 hepassocin 在肥胖中的作用。
Biofactors. 2020 Jan;46(1):100-105. doi: 10.1002/biof.1574. Epub 2019 Oct 6.
5
Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction.循环分泌卷曲相关蛋白 5 与急性 ST 段抬高型心肌梗死患者的慢性肾脏病。
Cytokine. 2018 Oct;110:367-373. doi: 10.1016/j.cyto.2018.04.009. Epub 2018 May 25.
6
Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病成人患者中无创纤维化标志物与慢性肾脏病的关联
PLoS One. 2014 Feb 10;9(2):e88569. doi: 10.1371/journal.pone.0088569. eCollection 2014.
7
Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris.血清脂肪细胞脂肪酸结合蛋白浓度升高与稳定性心绞痛患者肾功能障碍独立相关。
Cardiovasc Diabetol. 2012 Mar 21;11:26. doi: 10.1186/1475-2840-11-26.
8
Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up.中国成年人健康体检中无创诊断的肝脂肪变性与慢性肾脏病之间的关联
J Dig Dis. 2017 Apr;18(4):229-236. doi: 10.1111/1751-2980.12465.
9
Impact of chronic kidney disease on left main coronary artery disease and prognosis in Japanese patients.慢性肾脏病对日本患者左主干冠状动脉疾病及预后的影响。
Circ J. 2012;76(9):2266-72. doi: 10.1253/circj.cj-11-1455. Epub 2012 Jun 9.
10
The role of hepassocin in the development of non-alcoholic fatty liver disease.海帕西菌素在非酒精性脂肪性肝病发展中的作用。
J Hepatol. 2013 Nov;59(5):1065-72. doi: 10.1016/j.jhep.2013.06.004. Epub 2013 Jun 18.

引用本文的文献

1
The association between serum hepassocin levels and microalbuminuria in patients with type 2 diabetes mellitus.2型糖尿病患者血清肝素结合性表皮生长因子水平与微量白蛋白尿之间的关联。
Medicine (Baltimore). 2025 May 30;104(22):e42635. doi: 10.1097/MD.0000000000042635.
2
Critical Overview of Hepatic Factors That Link Non-Alcoholic Fatty Liver Disease and Acute Kidney Injury: Physiology and Therapeutic Implications.非酒精性脂肪性肝病与急性肾损伤相关的肝脏因素的批判性综述:生理学和治疗意义。
Int J Mol Sci. 2022 Oct 18;23(20):12464. doi: 10.3390/ijms232012464.
3
Low plasma growth/differentiation factor 1 levels are associated with liver fibrosis in patients with stable angina.

本文引用的文献

1
Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients.2型糖尿病患者慢性肾脏病与非酒精性脂肪性肝病之间的共同和独特因素及双向关系
Diabetes Metab Syndr Obes. 2020 Apr 17;13:1203-1214. doi: 10.2147/DMSO.S237700. eCollection 2020.
2
Unsaturated Fatty Acids Increase the Expression of Hepassocin through a Signal Transducer and Activator of Transcription 3-Dependent Pathway in HepG2 Cells.不饱和脂肪酸通过信号转导和转录激活因子3依赖途径增加HepG2细胞中肝激肽的表达。
Lipids. 2018 Sep;53(9):863-869. doi: 10.1002/lipd.12099.
3
低血浆生长/分化因子 1 水平与稳定型心绞痛患者的肝纤维化相关。
J Clin Lab Anal. 2022 Nov;36(11):e24745. doi: 10.1002/jcla.24745. Epub 2022 Oct 21.
4
Interactive effect of obesity and cognitive function decline on the risk of chronic kidney disease progression in patients with type 2 diabetes mellitus: a 9.1-year cohort study.肥胖和认知功能下降对 2 型糖尿病患者慢性肾脏病进展风险的交互作用:一项 9.1 年的队列研究。
Int J Med Sci. 2022 Sep 21;19(11):1660-1671. doi: 10.7150/ijms.75824. eCollection 2022.
5
Serum Fibrinogen-Like Protein 1 Levels in Obese Patients Before and After Laparoscopic Sleeve Gastrectomy: A Six-Month Longitudinal Study.肥胖患者腹腔镜袖状胃切除术前及术后血清纤维蛋白原样蛋白1水平:一项为期六个月的纵向研究
Diabetes Metab Syndr Obes. 2022 Aug 17;15:2511-2520. doi: 10.2147/DMSO.S374011. eCollection 2022.
6
Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.血清纤维蛋白原样蛋白 1 作为多囊卵巢综合征的一种新型生物标志物:一项病例对照研究。
J Endocrinol Invest. 2022 Nov;45(11):2123-2130. doi: 10.1007/s40618-022-01844-0. Epub 2022 Jul 5.
Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
慢性肾脏病患者中 2 型糖尿病的发病情况:来自慢性肾功能不全队列(CRIC)研究的结果。
Am J Kidney Dis. 2019 Jan;73(1):72-81. doi: 10.1053/j.ajkd.2018.06.017. Epub 2018 Sep 1.
4
Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle.肝脏中高血脂诱导的 hepassocin 导致骨骼肌胰岛素抵抗。
Mol Cell Endocrinol. 2018 Jul 15;470:26-33. doi: 10.1016/j.mce.2017.10.014. Epub 2017 Oct 28.
5
Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.肥胖儿童和青少年非酒精性脂肪性肝病(NAFLD)的病理生理学:最新进展
Nutr Hosp. 2017 Jun 5;34(3):727-730. doi: 10.20960/nh.723.
6
Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.循环内脂素水平与慢性乙型或丙型肝炎病毒感染中的肝细胞癌相关。
Cytokine. 2017 Feb;90:54-59. doi: 10.1016/j.cyto.2016.10.007. Epub 2016 Oct 19.
7
Insulin resistance in chronic kidney disease: a systematic review.慢性肾脏病中的胰岛素抵抗:一项系统综述。
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1087-F1108. doi: 10.1152/ajprenal.00340.2016. Epub 2016 Oct 5.
8
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.一种新型肝因子HFREP1在胰岛素抵抗和2型糖尿病的发展中起关键作用。
Diabetologia. 2016 Aug;59(8):1732-42. doi: 10.1007/s00125-016-3991-7. Epub 2016 May 25.
9
Associations among chronic kidney disease, high total p-cresylsulfate and left ventricular systolic dysfunction.慢性肾脏病、高对甲酚硫酸酯总量与左心室收缩功能障碍之间的关联。
Clin Chim Acta. 2016 Jun 1;457:63-8. doi: 10.1016/j.cca.2016.03.012. Epub 2016 Mar 29.
10
Update on inflammation in chronic kidney disease.慢性肾脏病炎症研究进展
Blood Purif. 2015;39(1-3):84-92. doi: 10.1159/000368940. Epub 2015 Jan 20.